Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

LYMPHOSEEK KIT

TECHNETIUM TC-99M TILMANOCEPT

Standard Dose
N/A
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview LYMPHOSEEK KIT is listed in Drugs@FDA under application 202207 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TECHNETIUM TC-99M TILMANOCEPT Form and strength INJECTABLE;INJECTION - N/A Sponsor CARDINAL HEALTH 414 Submission history Latest submission status date: 2021-05-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview LYMPHOSEEK KIT is listed in Drugs@FDA under application 202207 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TECHNETIUM TC-99M TILMANOCEPT Form and strength INJECTABLE;INJECTION - N/A Sponsor CARDINAL HEALTH 414 Submission history Latest submission status date: 2021-05-19 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.